Medicap Healthcare IPO
Upcoming MainboardAlready have an account? Apply now
Medicap Healthcare IPO details
About Medicap Healthcare
Medicap Healthcare Limited is an Indian pharmaceutical packaging company.
It was originally established in 2014 as a partnership firm and converted into a public limited company in 2017.
The Company is promoted by Kamalkumar Aggarwal, Rajveer Kamal Aggarwal and Minal Aggarwal. The Company operates in the pharmaceutical packaging and healthcare consumables segment.
Its manufacturing facility is located at GIDC Manjusar, Vadodara, Gujarat.
Operations focus on the production of pharmaceutical closures and related products. Medicap’s key offerings include Euro Head Caps and bottle preforms.
These products are primarily supplied to pharmaceutical and healthcare companies in India and overseas.
The Company follows a manufacturing-led business model with in-house production and quality control. Revenue is driven by long-term relationships with pharma customers and repeat demand.
The Company emphasises compliance with regulatory standards and product consistency.
Its strengths include a focused product portfolio, modern manufacturing infrastructure, and promoter experience in the pharma packaging industry.
Financials of Medicap Healthcare
Issue size
| Funds Raised in the IPO | Amount |
| Total issue size | 240 |
| Fresh Issue – Proceeds go to the company | 240 |
Utilisation of Proceeds
| Purpose | INR crores (%) |
|---|---|
|
Purchase of plant and machinery for the existing manufacturing unit |
74.37 (30.99%) |
| Pre-payment / repayment of borrowings | 32.9 (13.71%) |
| Investment in subsidiary (KASR Healthcare Pvt. Ltd.) for debt repayment | 52.8 (22%) |
| General corporate purposes | 79.93 (33.30%) |
Strengths
- Strong presence in pharma packaging with leadership in Euro Head Caps.
- Modern, integrated manufacturing facility with in-house production capabilities.
- Long-standing relationships with leading pharmaceutical customers.
- Promoter-led management with deep industry experience.
- Consistent revenue growth driven by repeat orders and regulated demand.
Risks
- High revenue dependence on a single product category (Euro Head Caps).
- Customer concentration with significant revenue from top clients.
- Operations are dependent on a single manufacturing facility in Gujarat.
- Exposure to regulatory and quality compliance risks in healthcare packaging.
- Dependence on imported raw materials exposes margins to forex volatility.